Neo-Minophagen C


Indications and Reactions:

Role Indications Reactions
Secondary
Infection 12.0%
Constipation 11.1%
Convulsion Prophylaxis 10.1%
Cerebral Infarction 8.8%
Wound Complication 8.3%
Drug Use For Unknown Indication 4.5%
Fluid Replacement 4.3%
Gastritis 4.0%
Pyrexia 4.0%
Hypertension 3.8%
Infection Prophylaxis 3.8%
Neurogenic Bladder 3.8%
Hyperglycaemia 3.5%
Gastric Ulcer 3.0%
Nutritional Support 3.0%
Vitamin Supplementation 3.0%
Asthma 2.5%
Sputum Retention 2.3%
Hepatic Function Abnormal 2.0%
Insomnia 2.0%
Stevens-johnson Syndrome 42.9%
Sepsis 11.9%
Endotoxic Shock 4.8%
Renal Failure Acute 4.8%
Toxic Epidermal Necrolysis 4.8%
Viral Myocarditis 4.8%
White Blood Cell Count Decreased 4.8%
Eosinophil Count Increased 2.4%
Inappropriate Antidiuretic Hormone Secretion 2.4%
Ischaemic Hepatitis 2.4%
Mental Disorder 2.4%
Neuroleptic Malignant Syndrome 2.4%
Overdose 2.4%
Pancytopenia 2.4%
Tachycardia 2.4%
White Blood Cell Count Increased 2.4%
Concomitant
Product Used For Unknown Indication 24.4%
Drug Use For Unknown Indication 11.2%
Prophylaxis 11.0%
Psoriatic Arthropathy 8.6%
Hepatitis C 7.2%
Hypertension 4.9%
Chronic Hepatitis C 4.2%
Hepatic Neoplasm Malignant 3.8%
Hiv Infection 3.7%
Constipation 2.8%
Liver Disorder 2.6%
Insomnia 2.4%
Antipyresis 2.2%
Hepatitis B 1.9%
Gastritis Prophylaxis 1.8%
Rheumatoid Arthritis 1.7%
Premedication 1.5%
Hepatic Function Abnormal 1.4%
Toxic Skin Eruption 1.4%
Upper Respiratory Tract Inflammation 1.3%
Liver Disorder 8.4%
Platelet Count Decreased 8.4%
Thrombocytopenia 8.4%
Histiocytosis Haematophagic 8.0%
Hepatic Cirrhosis 6.4%
White Blood Cell Count Decreased 5.6%
Pyrexia 5.2%
Hepatic Function Abnormal 4.8%
Vomiting 4.8%
Infection 4.4%
Rash 4.4%
Anaemia 3.6%
Pancreatitis Acute 3.6%
Renal Impairment 3.6%
Sepsis 3.6%
Stevens-johnson Syndrome 3.6%
White Blood Cell Count Increased 3.6%
Palmar-plantar Erythrodysaesthesia Syndrome 3.2%
Upper Gastrointestinal Haemorrhage 3.2%
Ascites 2.8%

Drug Data